An Autologous NK/CIK Cell Product (PB101) in Combination With EGFR-TKI for Treating Lung Cancer
Clinical trial NCT07271446 · COMPLETED
Trial details
- NCT number
- NCT07271446
- Sponsor
- Precision Biotech Taiwan Corp.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-01
- Primary completion
- 2019-08-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.